Medicare Enrolled
Dr. Ronald Rubenstein, M.D.
Urology Physician · Royal Oak, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rubenstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rubenstein?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rubenstein
Dr. Ronald Rubenstein is an urology physician in Royal Oak, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rubenstein performed 3,662 Medicare services across 2,539 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rubenstein received a total of $3,531 from 52 pharmaceutical and/or device companies across 177 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rubenstein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 16% volume in MI
$3,531 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,662
Medicare services
Top 16% in MI for urology physician
2,539
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~183 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,133 | $91 | $235 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,099 | $2 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
278 | $65 | $160 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 192 | $137 | $950 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
180 | $8 | $41 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
122 | $6 | $6 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
103 | $189 | $575 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
73 | $66 | $160 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
66 | $87 | $339 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
64 | $38 | $173 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
60 | $26 | $93 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
57 | $117 | $354 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
46 | $91 | $233 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
40 | $19 | $292 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
35 | $62 | $185 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
33 | $353 | $1,300 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
31 | $64 | $92 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
21 | $254 | $820 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
18 | $106 | $200 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
11 | $24 | $52 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.5% high complexity
11.2% medium
87.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,531
Total received (2018-2024)
Avg $504/year across 7 years
Top 42% in MI for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
177
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,376 (95.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$155 (4.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$430
2023
$666
2022
$765
2021
$622
2020
$365
2019
$203
2018
$481
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$103
Cycle Pharmaceuticals Inc
$67
Myriad Genetic Laboratories, Inc.
$51
Verity Pharmaceuticals Inc.
$46
Ferring Pharmaceuticals Inc.
$37
ABBVIE INC.
$30
PROGENICS PHARMACEUTICALS, INC.
$22
Laborie Medical Technologies Corp.
$21
UROGEN PHARMA, INC.
$19
Astellas Pharma US Inc
$17
Tolmar, Inc.
$16
Top 3 companies account for 51.5% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$770
Blue Earth Diagnostics Limited
$227
Myriad Genetic Laboratories, Inc.
$188
Sumitomo Pharma America, Inc.
$186
Endo Pharmaceuticals Inc.
$178
Janssen Biotech, Inc.
$141
Janssen Pharmaceuticals, Inc
$132
Dornier MedTech America, Inc
$105
Boston Scientific Corporation
$103
Bayer HealthCare Pharmaceuticals Inc.
$99
Coloplast Corp
$77
Antares Pharma, Inc.
$76
Sun Pharmaceutical Industries Inc.
$73
ABBVIE INC.
$72
Allergan, Inc.
$68
Cycle Pharmaceuticals Inc
$67
Dendreon Pharmaceuticals LLC
$61
AbbVie, Inc.
$56
UroGen Pharma, Inc.
$52
Laborie Medical Technologies Corp.
$50
Verity Pharmaceuticals Inc.
$46
Avadel Specialty Pharmaceuticals, LLC
$45
Allergan Inc.
$39
Ferring Pharmaceuticals Inc.
$37
Tolmar, Inc.
$33
UROVANT SCIENCES INC
$32
BAUDAX BIO INC.
$32
PROCEPT BioRobotics Corporation
$27
Olympus America Inc.
$27
Myovant Sciences Inc.
$27
Teleflex LLC
$25
Bayer Healthcare Pharmaceuticals Inc.
$23
180 Medical, Inc.
$22
Axonics, Inc.
$22
Merck Sharp & Dohme LLC
$22
PROGENICS PHARMACEUTICALS, INC.
$22
Novartis Pharmaceuticals Corporation
$21
TOLMAR Pharmaceuticals, Inc.
$21
ConvaTec Inc.
$20
UROGEN PHARMA, INC.
$19
Travere Therapeutics, Inc.
$19
Curium US LLC
$19
NeoTract Inc.
$18
Medtronic USA, Inc.
$17
Axonics Modulation Technologies, Inc.
$16
Merck Sharp & Dohme Corporation
$16
Clovis Oncology, Inc.
$15
Alnylam Pharmaceuticals Inc.
$14
COLOPLAST CORP
$13
AbbVie Inc.
$13
PFIZER INC.
$12
Cook Medical LLC
$12
Top 3 companies account for 33.6% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AFINITOR · ANJESO · AQUABEAM ROBOTIC SYSTEM · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · CONTINENCE CARE · Cook Medical Flexor · Dornier MedTech · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL BPH · GentleCath · INTERSTIM · INVOKANA · JELMYTO · KEYTRUDA · LUPRON DEPOT · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · OXLUMO · Optilume BPH Drug Coated Balloon Catheter · PROLARIS · PROVENGE · PYLARIFY · Prolaris · REZUM · Rubraca · SUTENT · SpeediCath · Thiola · Tiopronin · Tlando · UROLIFT · UroLift · VESICARE · Veozah · XIAFLEX · XTANDI · Xofigo · Xtandi · YONSA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
172
Per 100K population
13.5
County median income
$95,296
Nearest hospital
BEAUMONT HOSPITAL ROYAL OAK
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rubenstein is a clinical cardiology specialist, with above-average Medicare volume (top 16% in MI), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rubenstein experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rubenstein performed 1,133 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rubenstein receive payments from pharmaceutical companies?
Yes. Dr. Rubenstein received a total of $3,531 from 52 companies across 177 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rubenstein's costs compare to other urology physicians in Royal Oak?
Dr. Rubenstein's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rubenstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Royal Oak
Browse urology physicians in Royal Oak ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in MI
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in MI
Which MI urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Blue Earth Diagnostics Limited Payments to Doctors
See all physicians who received payments from Blue Earth Diagnostics Limited.
By company
Myriad Genetic Laboratories, Inc. Payments to Doctors
See all physicians who received payments from Myriad Genetic Laboratories, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology